ABVC BioPharma, Inc. Common Stock
Symbol: ABVC (NASDAQ)
2.72
▲ (1.46%) 0.039
Company Description:
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Key Stats
- Today's Open: $2.7
- Today's High: $2.73
- Today's Low: $2.68
- Today's Volume: 12.16K
- Yesterday Close: $2.68
- Yesterday High: $2.75
- Yesterday Low: $2.635
- Yesterday Volume: 65.27K
- Last Min Volume: 16
- Last Min High: $2.718
- Last Min Low: $2.712
- Last Min VWAP: $2.712
Company Profile
- Name: ABVC BioPharma, Inc. Common Stock
- Website: https://www.abvcpharma.com
- Listed Date: 2004-11-09
- Location: FREMONT, CA
- Market Status: Active
- CIK Number: 0001173313
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $63.09M
- Round Lot: 100
- Outstanding Shares: 23.54M
- Asset Type: CS
RECENT FILINGS FOR ABVC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-15 | 424B4 | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-13 | 10-Q | View |
| 2025-07-18 | 8-K/A | View |
| 2025-07-15 | SCHEDULE 13D/A | View |
| 2025-06-27 | S-8 | View |
| 2025-06-04 | 8-K | View |
| 2025-06-03 | SCHEDULE 13D | View |
| 2025-05-30 | 8-K/A | View |
| 2025-05-27 | POS AM | View |
| 2025-05-27 | POS AM | View |
| 2025-05-27 | POS AM | View |
| 2025-05-22 | S-3 | View |
| 2025-05-20 | EFFECT | View |
| 2025-05-20 | EFFECT | View |
Latest News on ABVC